Advertisement

Pathologic Fractures

  • Frank M. KlenkeEmail author
  • Attila Kollár
  • Christophe Kurze
Chapter
Part of the Fracture Management Joint by Joint book series (FMJJ)

Abstract

A bone fracture is termed pathologic when the fracture occurs through a region of a preexisting bone pathology weakening the bony architecture. Such pathologies include metabolic bone diseases such as Paget’s disease, osteogenesis imperfecta, and osteoporosis as well as local alterations of the bone structure due to tumorous processes and tumor-like bone lesions.

This chapter discussed pathologic fractures of the hip caused by the processes leading to local bone destruction including tumor-like lesions as well as primary and secondary (i.e., metastases) bone tumors.

Keywords

Pathologic fracture Bone Tumor Metastasis Tumor-like lesion Sarcoma Surgery Osteosynthesis Arthroplasty 

References

  1. 1.
    Aaron AD. Treatment of metastatic adenocarcinoma of the pelvis and the extremities. J Bone Joint Surg Am. 1997;79(6):917–32.PubMedCrossRefGoogle Scholar
  2. 2.
    Harrington KD. Orthopaedic management of extremity and pelvic lesions. Clin Orthop Relat Res. 1995;312:136–47.Google Scholar
  3. 3.
    Coleman RE. Metastatic bone disease: clinical features, pathophysiology and treatment strategies. Cancer Treat Rev. 2001;27(3):165–76.PubMedCrossRefGoogle Scholar
  4. 4.
    Harries M, Taylor A, Holmberg L, et al. Incidence of bone metastases and survival after a diagnosis of bone metastases in breast cancer patients. Cancer Epidemiol. 2014;38(4):427–34.PubMedCrossRefGoogle Scholar
  5. 5.
    Jensen AO, Jacobsen JB, Norgaard M, Yong M, Fryzek JP, Sorensen HT. Incidence of bone metastases and skeletal-related events in breast cancer patients: a population-based cohort study in Denmark. BMC Cancer. 2011;11:29.PubMedPubMedCentralCrossRefGoogle Scholar
  6. 6.
    Norgaard M, Jensen AO, Jacobsen JB, Cetin K, Fryzek JP, Sorensen HT. Skeletal related events, bone metastasis and survival of prostate cancer: a population based cohort study in Denmark (1999 to 2007). J Urol. 2010;184(1):162–7.PubMedCrossRefGoogle Scholar
  7. 7.
    Becker N. Epidemiology of multiple myeloma. Recent Results Cancer Res. 2011;183:25–35.PubMedCrossRefGoogle Scholar
  8. 8.
    Melton LJ 3rd, Kyle RA, Achenbach SJ, Oberg AL, Rajkumar SV. Fracture risk with multiple myeloma: a population-based study. J Bone Miner Res. 2005;20(3):487–93.PubMedCrossRefGoogle Scholar
  9. 9.
    Riccardi A, Gobbi PG, Ucci G, et al. Changing clinical presentation of multiple myeloma. Eur J Cancer. 1991;27(11):1401–5.PubMedCrossRefGoogle Scholar
  10. 10.
    Albergo JI, Gaston CL, Jeys LM, et al. Management and prognostic significance of pathological fractures through chondrosarcoma of the femur. Int Orthop. 2015;39(5):943–6.PubMedCrossRefGoogle Scholar
  11. 11.
    Bramer JA, Abudu AA, Grimer RJ, Carter SR, Tillman RM. Do pathological fractures influence survival and local recurrence rate in bony sarcomas? Eur J Cancer. 2007;43(13):1944–51.PubMedCrossRefGoogle Scholar
  12. 12.
    Andreou D, Ruppin S, Fehlberg S, Pink D, Werner M, Tunn PU. Survival and prognostic factors in chondrosarcoma: results in 115 patients with long-term follow-up. Acta Orthop. 2011;82(6):749–55.PubMedPubMedCentralCrossRefGoogle Scholar
  13. 13.
    Bacci G, Ferrari S, Longhi A, et al. Nonmetastatic osteosarcoma of the extremity with pathologic fracture at presentation: local and systemic control by amputation or limb salvage after preoperative chemotherapy. Acta Orthop Scand. 2003;74(4):449–54.PubMedCrossRefGoogle Scholar
  14. 14.
    Fuchs B, Valenzuela RG, Sim FH. Pathologic fracture as a complication in the treatment of Ewing’s sarcoma. Clin Orthop Relat Res. 2003;415:25–30.CrossRefGoogle Scholar
  15. 15.
    Scully SP, Ghert MA, Zurakowski D, Thompson RC, Gebhardt MC. Pathologic fracture in osteosarcoma : prognostic importance and treatment implications. J Bone Joint Surg Am. 2002;84-A(1):49–57.CrossRefGoogle Scholar
  16. 16.
    Ahn JI, Park JS. Pathological fractures secondary to unicameral bone cysts. Int Orthop. 1994;18(1):20–2.PubMedCrossRefGoogle Scholar
  17. 17.
    Azouz EM, Karamitsos C, Reed MH, Baker L, Kozlowski K, Hoeffel JC. Types and complications of femoral neck fractures in children. Pediatr Radiol. 1993;23(6):415–20.PubMedCrossRefGoogle Scholar
  18. 18.
    Papagelopoulos PJ, Choudhury SN, Frassica FJ, Bond JR, Unni KK, Sim FH. Treatment of aneurysmal bone cysts of the pelvis and sacrum. J Bone Joint Surg Am. 2001;83-A(11):1674–81.CrossRefGoogle Scholar
  19. 19.
    Mascard E, Gomez-Brouchet A, Lambot K. Bone cysts: unicameral and aneurysmal bone cyst. Orthop Traumatol Surg Res. 2015;101(1 Suppl):S119–27.PubMedCrossRefGoogle Scholar
  20. 20.
    Arata MA, Peterson HA, Dahlin DC. Pathological fractures through non-ossifying fibromas. Review of the Mayo Clinic experience. J Bone Joint Surg Am. 1981;63(6):980–8.PubMedCrossRefGoogle Scholar
  21. 21.
    Bali K, Sudesh P, Patel S, Kumar V, Saini U, Dhillon MS. Pediatric femoral neck fractures: our 10 years of experience. Clin Orthop Surg. 2011;3(4):302–8.PubMedPubMedCentralCrossRefGoogle Scholar
  22. 22.
    De Mattos CB, Binitie O, Dormans JP. Pathological fractures in children. Bone Joint Res. 2012;1(10):272–80.PubMedPubMedCentralCrossRefGoogle Scholar
  23. 23.
    Dormans JP, Hanna BG, Johnston DR, Khurana JS. Surgical treatment and recurrence rate of aneurysmal bone cysts in children. Clin Orthop Relat Res. 2004;421:205–11.CrossRefGoogle Scholar
  24. 24.
    Guille JT, Kumar SJ, MacEwen GD. Fibrous dysplasia of the proximal part of the femur. Long-term results of curettage and bone-grafting and mechanical realignment. J Bone Joint Surg Am. 1998;80(5):648–58.PubMedCrossRefGoogle Scholar
  25. 25.
    Krishnan H, Yoon TR, Park KS, Yeo JH. Eosinophilic granuloma involving the femoral neck. Case Rep Orthop. 2013;2013:809605.PubMedPubMedCentralGoogle Scholar
  26. 26.
    Mankin HJ, Hornicek FJ, Ortiz-Cruz E, Villafuerte J, Gebhardt MC. Aneurysmal bone cyst: a review of 150 patients. J Clin Oncol. 2005;23(27):6756–62.PubMedCrossRefGoogle Scholar
  27. 27.
    Ortiz EJ, Isler MH, Navia JE, Canosa R. Pathologic fractures in children. Clin Orthop Relat Res. 2005;432:116–26.Google Scholar
  28. 28.
    Tong Z, Zhang W, Jiao N, Wang K, Chen B, Yang T. Surgical treatment of fibrous dysplasia in the proximal femur. Exp Ther Med. 2013;5(5):1355–8.PubMedPubMedCentralCrossRefGoogle Scholar
  29. 29.
    Wai EK, Davis AM, Griffin A, Bell RS, Wunder JS. Pathologic fractures of the proximal femur secondary to benign bone tumors. Clin Orthop Relat Res. 2001;393:279–86.CrossRefGoogle Scholar
  30. 30.
    Leet AI, Boyce AM, Ibrahim KA, Wientroub S, Kushner H, Collins MT. Bone-grafting in polyostotic fibrous dysplasia. J Bone Joint Surg Am. 2016;98(3):211–9.PubMedPubMedCentralCrossRefGoogle Scholar
  31. 31.
    Stanton RP, Ippolito E, Springfield D, Lindaman L, Wientroub S, Leet A. The surgical management of fibrous dysplasia of bone. Orphanet J Rare Dis. 2012;7(Suppl 1):S1.PubMedPubMedCentralCrossRefGoogle Scholar
  32. 32.
    Hou HY, Wu K, Wang CT, Chang SM, Lin WH, Yang RS. Treatment of unicameral bone cyst: surgical technique. J Bone Joint Surg Am. 2011;93(Suppl 1):92–9.PubMedCrossRefGoogle Scholar
  33. 33.
    Kadhim M, Thacker M, Kadhim A, Holmes L Jr. Treatment of unicameral bone cyst: systematic review and meta analysis. J Child Orthop. 2014;8(2):171–91.PubMedPubMedCentralCrossRefGoogle Scholar
  34. 34.
    Easley ME, Kneisl JS. Pathologic fractures through nonossifying fibromas: is prophylactic treatment warranted? J Pediatr Orthop. 1997;17(6):808–13.Google Scholar
  35. 35.
    Hakim DN, Pelly T, Kulendran M, Caris JA. Benign tumours of the bone: a review. J Bone Oncol. 2015;4(2):37–41.PubMedPubMedCentralCrossRefGoogle Scholar
  36. 36.
    Fletcher CD. The evolving classification of soft tissue tumours - an update based on the new 2013 WHO classification. Histopathology. 2014;64(1):2–11.PubMedCrossRefGoogle Scholar
  37. 37.
    Haase SC. Treatment of pathologic fractures. Hand Clin. 2013;29(4):579–84.PubMedCrossRefGoogle Scholar
  38. 38.
    Sassoon AA, Fitz-Gibbon PD, Harmsen WS, Moran SL. Enchondromas of the hand: factors affecting recurrence, healing, motion, and malignant transformation. J Hand Surg Am. 2012;37(6):1229–34.CrossRefGoogle Scholar
  39. 39.
    Khoo RN, Peh WC, Guglielmi G. Clinics in diagnostic imaging (124). Multiple enchondromatosis in Ollier disease. Singap Med J. 2008;49(10):841–845; quiz 846.Google Scholar
  40. 40.
    Singh P, Kejariwal U, Chugh A. A rare occurrence of enchondroma in neck of femur in an adult female: a case report. J Clin Diagn Res. 2015;9(12):RD01–3.PubMedPubMedCentralGoogle Scholar
  41. 41.
    Murphey MD, Flemming DJ, Boyea SR, Bojescul JA, Sweet DE, Temple HT. Enchondroma versus chondrosarcoma in the appendicular skeleton: differentiating features. Radiographics. 1998;18(5):1213–37; quiz 1244-1215.PubMedCrossRefGoogle Scholar
  42. 42.
    Balke M, Schremper L, Gebert C, et al. Giant cell tumor of bone: treatment and outcome of 214 cases. J Cancer Res Clin Oncol. 2008;134(9):969–78.PubMedCrossRefGoogle Scholar
  43. 43.
    Klenke FM, Wenger DE, Inwards CY, Rose PS, Sim FH. Recurrent giant cell tumor of long bones: analysis of surgical management. Clin Orthop Relat Res. 2011;469(4):1181–7.PubMedCrossRefGoogle Scholar
  44. 44.
    Balke M, Streitbuerger A, Budny T, Henrichs M, Gosheger G, Hardes J. Treatment and outcome of giant cell tumors of the pelvis. Acta Orthop. 2009;80(5):590–6.PubMedPubMedCentralCrossRefGoogle Scholar
  45. 45.
    Blackley HR, Wunder JS, Davis AM, White LM, Kandel R, Bell RS. Treatment of giant-cell tumors of long bones with curettage and bone-grafting. J Bone Joint Surg Am. 1999;81(6):811–20.PubMedCrossRefGoogle Scholar
  46. 46.
    Campanacci M, Baldini N, Boriani S, Sudanese A. Giant-cell tumor of bone. J Bone Joint Surg Am. 1987;69(1):106–14.PubMedCrossRefGoogle Scholar
  47. 47.
    Larsson SE, Lorentzon R, Boquist L. Giant-cell tumor of bone. A demographic, clinical, and histopathological study of all cases recorded in the Swedish Cancer Registry for the years 1958 through 1968. J Bone Joint Surg Am. 1975;57(2):167–73.PubMedCrossRefGoogle Scholar
  48. 48.
    Sung HW, Kuo DP, Shu WP, Chai YB, Liu CC, Li SM. Giant-cell tumor of bone: analysis of two hundred and eight cases in Chinese patients. J Bone Joint Surg Am. 1982;64(5):755–61.PubMedCrossRefGoogle Scholar
  49. 49.
    Turcotte RE, Wunder JS, Isler MH, et al. Giant cell tumor of long bone: a Canadian Sarcoma Group study. Clin Orthop Relat Res. 2002;397:248–58.CrossRefGoogle Scholar
  50. 50.
    Benevenia J, Patterson FR, Beebe KS, Abdelshahed MM, Uglialoro AD. Comparison of phenol and argon beam coagulation as adjuvant therapies in the treatment of stage 2 and 3 benign-aggressive bone tumors. Orthopedics. 2012;35(3):e371–8.PubMedGoogle Scholar
  51. 51.
    Lewis VO, Wei A, Mendoza T, Primus F, Peabody T, Simon MA. Argon beam coagulation as an adjuvant for local control of giant cell tumor. Clin Orthop Relat Res. 2007;454:192–7.PubMedCrossRefGoogle Scholar
  52. 52.
    Klenke FM, Wenger DE, Inwards CY, Rose PS, Sim FH. Giant cell tumor of bone: risk factors for recurrence. Clin Orthop Relat Res. 2011;469(2):591–9.PubMedCrossRefGoogle Scholar
  53. 53.
    Mittag F, Leichtle C, Kieckbusch I, et al. Cytotoxic effect and tissue penetration of phenol for adjuvant treatment of giant cell tumours. Oncol Lett. 2013;5(5):1595–8.PubMedPubMedCentralCrossRefGoogle Scholar
  54. 54.
    van der Heijden L, Dijkstra PD, Campanacci DA, Gibbons CL, van de Sande MA. Giant cell tumor with pathologic fracture: should we curette or resect? Clin Orthop Relat Res. 2013;471(3):820–9.PubMedCrossRefGoogle Scholar
  55. 55.
    Deheshi BM, Jaffer SN, Griffin AM, Ferguson PC, Bell RS, Wunder JS. Joint salvage for pathologic fracture of giant cell tumor of the lower extremity. Clin Orthop Relat Res. 2007;459:96–104.PubMedCrossRefGoogle Scholar
  56. 56.
    Zheng K, Yu X, Hu Y, Wang Z, Wu S, Ye Z. Surgical treatment for pelvic giant cell tumor: a multi-center study. World J Surg Oncol. 2016;14:104.PubMedPubMedCentralCrossRefGoogle Scholar
  57. 57.
    Chung LH, Wu PK, Chen CF, Weng HK, Chen TH, Chen WM. Pathological fractures in predicting clinical outcomes for patients with osteosarcoma. BMC Musculoskelet Disord. 2016;17(1):503.PubMedPubMedCentralCrossRefGoogle Scholar
  58. 58.
    Moradi B, Zahlten-Hinguranage A, Lehner B, Zeifang F. The impact of pathological fractures on therapy outcome in patients with primary malignant bone tumours. Int Orthop. 2010;34(7):1017–23.PubMedCrossRefGoogle Scholar
  59. 59.
    Schlegel M, Zeumer M, Prodinger PM, et al. Impact of pathological fractures on the prognosis of primary malignant bone sarcoma in children and adults: a single-center retrospective study of 205 patients. Oncology. 2018;94(6):354–62.PubMedCrossRefGoogle Scholar
  60. 60.
    Sun L, Li Y, Zhang J, Li H, Li B, Ye Z. Prognostic value of pathologic fracture in patients with high grade localized osteosarcoma: a systemic review and meta-analysis of cohort studies. J Orthop Res. 2015;33(1):131–9.PubMedCrossRefGoogle Scholar
  61. 61.
    Zeifang F, Sabo D, Ewerbeck V. [Pathological fracture in primary malignant bone tumors]. Chirurg. 2000;71(9):1121–5.CrossRefGoogle Scholar
  62. 62.
    Zuo D, Zheng L, Sun W, Hua Y, Cai Z. Pathologic fracture does not influence prognosis in stage IIB osteosarcoma: a case-control study. World J Surg Oncol. 2013;11:148.PubMedPubMedCentralCrossRefGoogle Scholar
  63. 63.
    Chandrasekar CR, Grimer RJ, Carter SR, Tillman RM, Abudu A, Buckley L. Modular endoprosthetic replacement for tumours of the proximal femur. J Bone Joint Surg Br. 2009;91(1):108–12.PubMedCrossRefGoogle Scholar
  64. 64.
    Kawaguchi N, Ahmed AR, Matsumoto S, Manabe J, Matsushita Y. The concept of curative margin in surgery for bone and soft tissue sarcoma. Clin Orthop Relat Res. 2004;419:165–72.CrossRefGoogle Scholar
  65. 65.
    Chen X, Yu LJ, Peng HM, et al. Is intralesional resection suitable for central grade 1 chondrosarcoma: a systematic review and updated meta-analysis. Eur J Surg Oncol. 2017;43(9):1718–26.PubMedCrossRefGoogle Scholar
  66. 66.
    Chen YC, Wu PK, Chen CF, Chen WM. Intralesional curettage of central low-grade chondrosarcoma: a midterm follow-up study. J Chin Med Assoc. 2017;80(3):178–82.PubMedCrossRefGoogle Scholar
  67. 67.
    Meftah M, Schult P, Henshaw RM. Long-term results of intralesional curettage and cryosurgery for treatment of low-grade chondrosarcoma. J Bone Joint Surg Am. 2013;95(15):1358–64.PubMedCrossRefGoogle Scholar
  68. 68.
    Weber KL, Raymond AK. Low-grade/dedifferentiated/high-grade chondrosarcoma: a case of histological and biological progression. Iowa Orthop J. 2002;22:75–80.PubMedPubMedCentralGoogle Scholar
  69. 69.
    Deloin X, Dumaine V, Biau D, et al. Pelvic chondrosarcomas: surgical treatment options. Orthop Traumatol Surg Res. 2009;95(6):393–401.PubMedCrossRefGoogle Scholar
  70. 70.
    Pring ME, Weber KL, Unni KK, Sim FH. Chondrosarcoma of the pelvis. A review of sixty-four cases. J Bone Joint Surg Am. 2001;83-A(11):1630–42.CrossRefGoogle Scholar
  71. 71.
    Brown TS, Salib CG, Rose PS, Sim FH, Lewallen DG, Abdel MP. Reconstruction of the hip after resection of periacetabular oncological lesions: a systematic review. Bone Joint J. 2018;100-B(1 Supple A):22–30.PubMedPubMedCentralCrossRefGoogle Scholar
  72. 72.
    Bus MP, Szafranski A, Sellevold S, et al. LUMiC((R)) endoprosthetic reconstruction after periacetabular tumor resection: short-term results. Clin Orthop Relat Res. 2017;475(3):686–95.PubMedCrossRefGoogle Scholar
  73. 73.
    Hong AM, Millington S, Ahern V, et al. Limb preservation surgery with extracorporeal irradiation in the management of malignant bone tumor: the oncological outcomes of 101 patients. Ann Oncol. 2013;24(10):2676–80.PubMedCrossRefGoogle Scholar
  74. 74.
    Liang H, Ji T, Zhang Y, Wang Y, Guo W. Reconstruction with 3D-printed pelvic endoprostheses after resection of a pelvic tumour. Bone Joint J. 2017;99-B(2):267–75.PubMedCrossRefGoogle Scholar
  75. 75.
    Sharma DN, Rastogi S, Bakhshi S, et al. Role of extracorporeal irradiation in malignant bone tumors. Indian J Cancer. 2013;50(4):306–9.PubMedCrossRefGoogle Scholar
  76. 76.
    Sun W, Li J, Li Q, Li G, Cai Z. Clinical effectiveness of hemipelvic reconstruction using computer-aided custom-made prostheses after resection of malignant pelvic tumors. J Arthroplast. 2011;26(8):1508–13.CrossRefGoogle Scholar
  77. 77.
    Thambapillary S, Dimitriou R, Makridis KG, Fragkakis EM, Bobak P, Giannoudis PV. Implant longevity, complications and functional outcome following proximal femoral arthroplasty for musculoskeletal tumors: a systematic review. J Arthroplasty. 2013;28(8):1381–5.PubMedCrossRefGoogle Scholar
  78. 78.
    Goorin AM, Schwartzentruber DJ, Devidas M, et al. Presurgical chemotherapy compared with immediate surgery and adjuvant chemotherapy for nonmetastatic osteosarcoma: Pediatric Oncology Group Study POG-8651. J Clin Oncol. 2003;21(8):1574–80.PubMedCrossRefGoogle Scholar
  79. 79.
    Choy WS, Kim KJ, Lee SK, et al. Surgical treatment of pathological fractures occurring at the proximal femur. Yonsei Med J. 2015;56(2):460–5.PubMedPubMedCentralCrossRefGoogle Scholar
  80. 80.
    Issack PS, Kotwal SY, Lane JM. Management of metastatic bone disease of the acetabulum. J Am Acad Orthop Surg. 2013;21(11):685–95.PubMedCrossRefGoogle Scholar
  81. 81.
    Mundy GR. Metastasis to bone: causes, consequences and therapeutic opportunities. Nat Rev Cancer. 2002;2(8):584–93.PubMedCrossRefGoogle Scholar
  82. 82.
    Roudier MP, Vesselle H, True LD, et al. Bone histology at autopsy and matched bone scintigraphy findings in patients with hormone refractory prostate cancer: the effect of bisphosphonate therapy on bone scintigraphy results. Clin Exp Metastasis. 2003;20(2):171–80.PubMedCrossRefGoogle Scholar
  83. 83.
    Gainor BJ, Buchert P. Fracture healing in metastatic bone disease. Clin Orthop Relat Res. 1983;178:297–302.Google Scholar
  84. 84.
    Bohm P, Huber J. The surgical treatment of bony metastases of the spine and limbs. J Bone Joint Surg Br. 2002;84(4):521–9.PubMedCrossRefGoogle Scholar
  85. 85.
    Jacofsky DJ, Haidukewych GJ. Management of pathologic fractures of the proximal femur: state of the art. J Orthop Trauma. 2004;18(7):459–69.PubMedCrossRefGoogle Scholar
  86. 86.
    Errani C, Mavrogenis AF, Cevolani L, et al. Treatment for long bone metastases based on a systematic literature review. Eur J Orthop Surg Traumatol. 2017;27(2):205–11.PubMedCrossRefGoogle Scholar
  87. 87.
    Forsberg JA, Eberhardt J, Boland PJ, Wedin R, Healey JH. Estimating survival in patients with operable skeletal metastases: an application of a Bayesian belief network. PLoS One. 2011;6(5):e19956.PubMedPubMedCentralCrossRefGoogle Scholar
  88. 88.
    Katagiri H, Okada R, Takagi T, et al. New prognostic factors and scoring system for patients with skeletal metastasis. Cancer Med. 2014;3(5):1359–67.PubMedPubMedCentralCrossRefGoogle Scholar
  89. 89.
    Ratasvuori M, Wedin R, Hansen BH, et al. Prognostic role of en-bloc resection and late onset of bone metastasis in patients with bone-seeking carcinomas of the kidney, breast, lung, and prostate: SSG study on 672 operated skeletal metastases. J Surg Oncol. 2014;110(4):360–5.PubMedCrossRefGoogle Scholar
  90. 90.
    Rougraff BT, Kneisl JS, Simon MA. Skeletal metastases of unknown origin. A prospective study of a diagnostic strategy. J Bone Joint Surg Am. 1993;75(9):1276–81.PubMedCrossRefGoogle Scholar
  91. 91.
    Wolanczyk MJ, Fakhrian K, Adamietz IA. Radiotherapy, bisphosphonates and surgical stabilization of complete or impending pathologic fractures in patients with metastatic bone disease. J Cancer. 2016;7(1):121–4.PubMedPubMedCentralCrossRefGoogle Scholar
  92. 92.
    Muller DA, Capanna R. The surgical treatment of pelvic bone metastases. Adv Orthop. 2015;2015:525363.PubMedPubMedCentralCrossRefGoogle Scholar
  93. 93.
    Nilsson J, Gustafson P. Surgery for metastatic lesions of the femur: good outcome after 245 operations in 216 patients. Injury. 2008;39(4):404–10.PubMedCrossRefGoogle Scholar
  94. 94.
    Morishige M, Muramatsu K, Tominaga Y, Hashimoto T, Taguchi T. Surgical treatment of metastatic femoral fractures: achieving an improved quality of life for cancer patients. Anticancer Res. 2015;35(1):427–32.PubMedGoogle Scholar
  95. 95.
    Mirels H. Metastatic disease in long bones. A proposed scoring system for diagnosing impending pathologic fractures. Clin Orthop Relat Res. 1989;249:256–64.Google Scholar
  96. 96.
    Damron TA, Morgan H, Prakash D, Grant W, Aronowitz J, Heiner J. Critical evaluation of Mirels’ rating system for impending pathologic fractures. Clin Orthop Relat Res. 2003;415:S201–7.CrossRefGoogle Scholar
  97. 97.
    Van der Linden YM, Dijkstra PD, Kroon HM, et al. Comparative analysis of risk factors for pathological fracture with femoral metastases. J Bone Joint Surg Br. 2004;86(4):566–73.PubMedCrossRefGoogle Scholar
  98. 98.
    Menck H, Schulze S, Larsen E. Metastasis size in pathologic femoral fractures. Acta Orthop Scand. 1988;59(2):151–4.PubMedCrossRefGoogle Scholar
  99. 99.
    Issack PS, Barker J, Baker M, Kotwal SY, Lane JM. Surgical management of metastatic disease of the proximal part of the femur. J Bone Joint Surg Am. 2014;96(24):2091–8.PubMedCrossRefGoogle Scholar
  100. 100.
    Peterson JR, Decilveo AP, O’Connor IT, Golub I, Wittig JC. What are the functional results and complications with long stem hemiarthroplasty in patients with metastases to the proximal femur? Clin Orthop Relat Res. 2017;475(3):745–56.PubMedCrossRefGoogle Scholar
  101. 101.
    Steensma M, Boland PJ, Morris CD, Athanasian E, Healey JH. Endoprosthetic treatment is more durable for pathologic proximal femur fractures. Clin Orthop Relat Res. 2012;470(3):920–6.PubMedCrossRefGoogle Scholar
  102. 102.
    Wedin R, Bauer HC. Surgical treatment of skeletal metastatic lesions of the proximal femur: endoprosthesis or reconstruction nail? J Bone Joint Surg Br. 2005;87(12):1653–7.PubMedCrossRefGoogle Scholar
  103. 103.
    Yazawa Y, Frassica FJ, Chao EY, Pritchard DJ, Sim FH, Shives TC. Metastatic bone disease. A study of the surgical treatment of 166 pathologic humeral and femoral fractures. Clin Orthop Relat Res. 1990;251:213–9.Google Scholar
  104. 104.
    Capanna R, Campanacci DA. The treatment of metastases in the appendicular skeleton. J Bone Joint Surg Br. 2001;83(4):471–81.PubMedCrossRefGoogle Scholar
  105. 105.
    Alvi HM, Damron TA. Prophylactic stabilization for bone metastases, myeloma, or lymphoma: do we need to protect the entire bone? Clin Orthop Relat Res. 2013;471(3):706–14.PubMedCrossRefGoogle Scholar
  106. 106.
    Scarborough MT. CORR Insights (R): Intramedullary nailing of femoral diaphyseal metastases: is it necessary to protect the femoral neck? Clin Orthop Relat Res. 2015;473(4):1503–4.PubMedCrossRefGoogle Scholar
  107. 107.
    Miller BJ, Soni EE, Gibbs CP, Scarborough MT. Intramedullary nails for long bone metastases: why do they fail? Orthopedics. 2011;34(4):274.Google Scholar
  108. 108.
    Friedl W. [Double plate compound osteosynthesis. A procedure for primary stress-stable management of problem injuries of the subtrochanteric to supracondylar femoral area]. Aktuelle Traumatol. 1992;22(5):189–96.Google Scholar
  109. 109.
    Gruber G, Zacherl M, Leithner A, et al. [Surgical treatment of pathologic fractures of the humerus and femur]. Orthopade. 2009;38(4):324, 326–8, 330–4.PubMedCrossRefGoogle Scholar
  110. 110.
    Friedl W, Ruf W, Mischkowsky T. [Compound double plate osteosynthesis in subtrochanteric pathologic fractures. A clinical and experimental study]. Chirurg. 1986;57(11):713–18.Google Scholar
  111. 111.
    Ganz R, Fernandez D. [Treatment of pathological fractures in metastases]. Ther Umsch. 1973;30(4):307–9.Google Scholar
  112. 112.
    Schottle H, Sauer HD, Jungbluth KH. [Measurements of stability of operative osteosynthesis on the proximal femur (author’s transl)]. Arch Orthop Unfallchir. 1977;89(1):87–100.Google Scholar
  113. 113.
    Rompe JD, Eysel P, Hopf C, Heine J. Metastatic instability at the proximal end of the femur. Comparison of endoprosthetic replacement and plate osteosynthesis. Arch Orthop Trauma Surg. 1994;113(5):260–4.PubMedCrossRefGoogle Scholar
  114. 114.
    Merckaert S, Siebenrock K, Tannast M. Compound osteosynthesis of the proximal femur as a choice for the treatment of pathological proximal femoral fractures. American Academy of Orthoppaedic Surgerons (AAOS) Annual Meeting, San Diego, USA; 2017.Google Scholar
  115. 115.
    Picci P, Manfrini M, Fabbri N, Gambarotti M, Vanel D. Atlas of musculoskeletal tumors and tumorlike lesions. Berlin: Springer; 2014.CrossRefGoogle Scholar
  116. 116.
    Yasko AW, Rutledge J, Lewis VO, Lin PP. Disease- and recurrence-free survival after surgical resection of solitary bone metastases of the pelvis. Clin Orthop Relat Res. 2007;459:128–32.PubMedCrossRefGoogle Scholar
  117. 117.
    Harrington KD. The management of acetabular insufficiency secondary to metastatic malignant disease. J Bone Joint Surg Am. 1981;63(4):653–64.PubMedCrossRefGoogle Scholar
  118. 118.
    Cotten A, Deprez X, Migaud H, Chabanne B, Duquesnoy B, Chastanet P. Malignant acetabular osteolyses: percutaneous injection of acrylic bone cement. Radiology. 1995;197(1):307–10.PubMedCrossRefGoogle Scholar
  119. 119.
    Guzik G. Treatment of metastatic lesions localized in the acetabulum. J Orthop Surg Res. 2016;11(1):54.PubMedPubMedCentralCrossRefGoogle Scholar
  120. 120.
    Scaramuzzo L, Maccauro G, Rossi B, Messuti L, Maffulli N, Logroscino CA. Quality of life in patients following percutaneous PMMA acetabuloplasty for acetabular metastasis due to carcinoma. Acta Orthop Belg. 2009;75(4):484–9.PubMedGoogle Scholar
  121. 121.
    Clayer M. The survivorship of protrusio cages for metastatic disease involving the acetabulum. Clin Orthop Relat Res. 2010;468(11):2980–4.PubMedPubMedCentralCrossRefGoogle Scholar
  122. 122.
    Ho L, Ahlmann ER, Menendez LR. Modified Harrington reconstruction for advanced periacetabular metastatic disease. J Surg Oncol. 2010;101(2):170–4.PubMedGoogle Scholar
  123. 123.
    Marco RA, Sheth DS, Boland PJ, Wunder JS, Siegel JA, Healey JH. Functional and oncological outcome of acetabular reconstruction for the treatment of metastatic disease. J Bone Joint Surg Am. 2000;82(5):642–51.PubMedCrossRefGoogle Scholar
  124. 124.
    Tillman RM, Myers GJ, Abudu AT, Carter SR, Grimer RJ. The three-pin modified ‘Harrington’ procedure for advanced metastatic destruction of the acetabulum. J Bone Joint Surg Br. 2008;90(1):84–7.PubMedCrossRefGoogle Scholar
  125. 125.
    Kitagawa Y, Ek ET, Choong PF. Pelvic reconstruction using saddle prosthesis following limb salvage operation for periacetabular tumour. J Orthop Surg (Hong Kong). 2006;14(2):155–62.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Frank M. Klenke
    • 1
    Email author
  • Attila Kollár
    • 2
  • Christophe Kurze
    • 1
  1. 1.Department of Orthopaedic Surgery and Traumatology, InselspitalBern University HospitalBernSwitzerland
  2. 2.Department of Medical Oncology, InselspitalBern University HospitalBernSwitzerland

Personalised recommendations